BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 31708785)

  • 21. Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities.
    Kashyap BK; Singh VV; Solanki MK; Kumar A; Ruokolainen J; Kesari KK
    ACS Omega; 2023 Apr; 8(16):14290-14320. PubMed ID: 37125102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticles derived from naturally occurring metal chelators for theranostic applications.
    Jung W; Lee DY; Moon E; Jon S
    Adv Drug Deliv Rev; 2022 Dec; 191():114620. PubMed ID: 36379406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
    Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
    Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smart Multifunctional Nanoparticles in Cancer Theranostics: Progress and Prospect.
    Karati D; Mukherjee S; Dutta A; Ash D; Ganguly SC; Acharya A; Basu B
    Pharm Nanotechnol; 2024 May; ():. PubMed ID: 38756071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gold-Based Nanomaterials for Applications in Nanomedicine.
    Ashraf S; Pelaz B; del Pino P; Carril M; Escudero A; Parak WJ; Soliman MG; Zhang Q; Carrillo-Carrion C
    Top Curr Chem; 2016; 370():169-202. PubMed ID: 26589509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-like nanoparticles as a theranostic platform for cancer.
    Kim KR; Lee AS; Kim SM; Heo HR; Kim CS
    Front Bioeng Biotechnol; 2022; 10():1106767. PubMed ID: 36714624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer.
    Mukherjee A; Paul M; Mukherjee S
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.
    Pijeira MSO; Viltres H; Kozempel J; Sakmár M; Vlk M; İlem-Özdemir D; Ekinci M; Srinivasan S; Rajabzadeh AR; Ricci-Junior E; Alencar LMR; Al Qahtani M; Santos-Oliveira R
    EJNMMI Radiopharm Chem; 2022 Apr; 7(1):8. PubMed ID: 35467307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface Engineering of Nanoparticles toward Cancer Theranostics.
    Huang P; Wang C; Deng H; Zhou Y; Chen X
    Acc Chem Res; 2023 Jul; 56(13):1766-1779. PubMed ID: 37314368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
    Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI
    Front Chem; 2022; 10():830133. PubMed ID: 35494646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current state and prospects of the phytosynthesized colloidal gold nanoparticles and their applications in cancer theranostics.
    Ovais M; Raza A; Naz S; Islam NU; Khalil AT; Ali S; Khan MA; Shinwari ZK
    Appl Microbiol Biotechnol; 2017 May; 101(9):3551-3565. PubMed ID: 28382454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymeric multifunctional nanomaterials for theranostics.
    Peng H; Liu X; Wang G; Li M; Bratlie KM; Cochran E; Wang Q
    J Mater Chem B; 2015 Sep; 3(34):6856-6870. PubMed ID: 32262535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantum dots in nanomedicine: recent trends, advances and unresolved issues.
    Volkov Y
    Biochem Biophys Res Commun; 2015 Dec; 468(3):419-27. PubMed ID: 26168726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics.
    Khan MA; Singh D; Ahmad A; Siddique HR
    Eur J Pharm Sci; 2021 Sep; 164():105892. PubMed ID: 34052295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of nanoparticles and nanomaterials in cancer diagnosis and treatment: a comprehensive review.
    Lan H; Jamil M; Ke G; Dong N
    Am J Cancer Res; 2023; 13(12):5751-5784. PubMed ID: 38187049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctional Photonic Nanomaterials for Diagnostic, Therapeutic, and Theranostic Applications.
    Kim H; Beack S; Han S; Shin M; Lee T; Park Y; Kim KS; Yetisen AK; Yun SH; Kwon W; Hahn SK
    Adv Mater; 2018 Mar; 30(10):. PubMed ID: 29363198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging- Guided Photothermal and Photodynamic Therapy of Cancer.
    Rajkumar S; Prabaharan M
    Curr Top Med Chem; 2017; 17(16):1858-1871. PubMed ID: 27875977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.